Direct Printing of Bioceramic Implants with Spatially Localized Angiogenic Factors
Source abstract
Abstract
Direct printing of brushite and hydroxyapatite bioceramics at room temperature is used to construct model implants onto which the angiogenic compounds vascular endothelial growth factor (VEGF) and copper sulfate were adsorbed. This low-temperature direct approach offers several practical advantages and may find application in bone grafting. The figure shows examples of complex shapes made of brushite.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · 3D Printing in Biomedical Research · Collagen: Extraction and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (29)
Show source-provided references
1. 10.1016/j.biomaterials.2004.09.05610.1016/j.biomaterials.2004.09.056 ↗
2. 10.1016/j.biomaterials.2005.02.00210.1016/j.biomaterials.2005.02.002 ↗
3. 10.1016/S0166-3615(98)00125-010.1016/S0166-3615(98)00125-0 ↗
4. 10.1016/j.tibtech.2004.10.00410.1016/j.tibtech.2004.10.004 ↗
5. 10.1023/B:JMSM.0000046393.81449.a510.1023/B:JMSM.0000046393.81449.a5 ↗
6. 10.1002/jbm.b.3029110.1002/jbm.b.30291 ↗
7. Sadeghian Z. · CFI, Ceram. Forum Int. · 2004 · 81 · E39
8. 10.1002/jbm.a.2001510.1002/jbm.a.20015 ↗
9. 10.1108/1355254051062363910.1108/13552540510623639 ↗
10. 10.1023/A:101850030996910.1023/A:1018500309969 ↗
11. 10.1038/nm119010.1038/nm1190 ↗
12. 10.1302/0301-620X.87B10.1622610.1302/0301-620X.87B10.16226 ↗
13. FDA Public Health Notification: Update of Information about BioMedical Tissue Services http://www.fda.gov/cber/safety/bts030206.htm(accessed November 2006).
14. 10.3171/spi.2005.2.5.052110.3171/spi.2005.2.5.0521 ↗
15. 10.1097/01.brs.0000137062.79201.9810.1097/01.brs.0000137062.79201.98 ↗
16. 10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A ↗
17. Parke A. · Am. J. Pathol. · 1988 · 130 · 173
18. 10.1152/ajpheart.01015.200110.1152/ajpheart.01015.2001 ↗
19. 10.1016/j.biomaterials.2004.08.02710.1016/j.biomaterials.2004.08.027 ↗
20. 10.1016/j.biomaterials.2005.03.04910.1016/j.biomaterials.2005.03.049 ↗
21. 10.1177/15440591040830030410.1177/154405910408300304 ↗
22. 10.1126/science.150.3698.89310.1126/science.150.3698.893 ↗
23. 10.1016/0040-8166(86)90026-110.1016/0040-8166(86)90026-1 ↗
24. 10.1097/00003086-199202000-0004310.1097/00003086-199202000-00043 ↗
25. 10.1359/jbmr.1998.13.5.82810.1359/jbmr.1998.13.5.828 ↗
26. 10.1016/S0300-483X(03)00159-810.1016/S0300-483X(03)00159-8 ↗
27. Helgeland K. · Scand. J. Clin. Lab. Invest. · 1982 · 42 · 35
28. Hebert C. · Natl. Toxicol. Program Toxic. Rep. Ser. · 1993 · 29 · 1D3
29. J. C. Elliott Structure and Chemistry of the Apatites and Other Calcium Orthophosphates Elsevier Amsterdam The Netherlands1994 pp. 8–51.